Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Manhattan Street Capital is an online fundraising platform and advisory firm that specializes in helping mid-stage companies and mature startups raise capital through Regulation A+, Regulation D, and Regulation S. Based in San Diego, California, the company provides a comprehensive suite of services including project management, technology integration, and investor marketing to facilitate IPOs to the NASDAQ and NYSE. While the platform serves a variety of industries, it maintains a strong focus on the biotechnology, healthcare, and artificial intelligence sectors, having hosted offerings for companies like Genprex and GATC Health. The firm was founded in 2014 by Rod Turner, a veteran tech executive with experience in major IPOs such as Symantec and Ashton-Tate. Manhattan Street Capital also operates Fund Athena, a program dedicated to supporting women-led businesses in their fundraising efforts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Manhattan Street Capital.